FDA Authorizes Second Dose of Updated Covid Booster for Seniors and Immunocompromised

Unvaccinated individuals will receive only updated bivalent vaccine dose going forward.
Original monovalent vaccines no longer authorized in U.S.
Seniors 65 and older eligible for second bivalent booster four months after first, while immunocompromised can receive additional dose after two months and more doses at doctor's discretion.
CDC recommends bivalent booster for anyone 6 and older to provide maximum protection against severe disease and death.
Annual COVID vaccination campaign planned to match recommendations for influenza immunization.